Crossing the Blood–Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies
The blood–brain barrier (BBB) is a highly selective and natural protective membrane that restricts the entry of therapeutic agents into the central nervous system (CNS). This restrictive nature poses a major challenge for pharmacological treatment of a wide range of CNS disorders, including neurodeg...
Saved in:
Main Authors: | Ling Ding, Pratiksha Kshirsagar, Prachi Agrawal, Daryl J. Murry |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/6/706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
by: Jason Tien, et al.
Published: (2023-12-01) -
Engineered nanomaterials for overcoming multifaceted gastrointestinal barriers: Toward precision oral delivery of therapeutics
by: Yuxin Liu, et al.
Published: (2025-08-01) -
Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier
by: Song Wang, et al.
Published: (2025-06-01) -
Hypertension promotes neuroinflammation, brain injury and cognitive impairment
by: Quynh Nhu Dinh, et al.
Published: (2025-10-01) -
Pathoanatomical Pattern of Brain Damage of White Mice Infected with Experimental Anthrax
by: D. D. Briukhova, et al.
Published: (2020-03-01)